RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sam Chun Dang Pharm Co Stock

Sam Chun Dang Pharm Co EBIT 2025

Sam Chun Dang Pharm Co EBIT

2.64 B KRW

Ticker

000250.KQ

ISIN

KR7000250001

In 2025, Sam Chun Dang Pharm Co's EBIT was 2.64 B KRW, a -72.36% increase from the 9.56 B KRW EBIT recorded in the previous year.

The Sam Chun Dang Pharm Co EBIT history

YEAREBIT (undefined KRW)
20242.64
20239.56
202212.22
2021-15.29
20205.52
201925.21
201815.5
201723.97
201624.36
201520.76
201418.94
201315.88
20125.96
20117.5

Sam Chun Dang Pharm Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Sam Chun Dang Pharm Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Sam Chun Dang Pharm Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Sam Chun Dang Pharm Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Sam Chun Dang Pharm Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Sam Chun Dang Pharm Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Sam Chun Dang Pharm Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Sam Chun Dang Pharm Co’s growth potential.

Sam Chun Dang Pharm Co Revenue, EBIT and net profit per share

DateSam Chun Dang Pharm Co RevenueSam Chun Dang Pharm Co EBITSam Chun Dang Pharm Co Net Income
2024210.92 B undefined2.64 B undefined-10.92 B undefined
2023192.67 B undefined9.56 B undefined-10.38 B undefined
2022177.34 B undefined12.22 B undefined5.84 B undefined
2021167.27 B undefined-15.29 B undefined-16.56 B undefined
2020166.86 B undefined5.52 B undefined-966 M undefined
2019186.6 B undefined25.21 B undefined10.45 B undefined
2018159.96 B undefined15.5 B undefined8.75 B undefined
2017160.59 B undefined23.97 B undefined12.52 B undefined
2016147.37 B undefined24.36 B undefined8.71 B undefined
2015132.06 B undefined20.76 B undefined11.63 B undefined
2014118.92 B undefined18.94 B undefined11.85 B undefined
2013104.54 B undefined15.88 B undefined8.72 B undefined
201276.65 B undefined5.96 B undefined1.34 B undefined
201177.57 B undefined7.5 B undefined5.66 B undefined

Sam Chun Dang Pharm Co stock margins

The Sam Chun Dang Pharm Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sam Chun Dang Pharm Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sam Chun Dang Pharm Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Sam Chun Dang Pharm Co's sales revenue. A higher gross margin percentage indicates that the Sam Chun Dang Pharm Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Sam Chun Dang Pharm Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Sam Chun Dang Pharm Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Sam Chun Dang Pharm Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Sam Chun Dang Pharm Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Sam Chun Dang Pharm Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Sam Chun Dang Pharm Co Margin History

Sam Chun Dang Pharm Co Gross marginSam Chun Dang Pharm Co Profit marginSam Chun Dang Pharm Co EBIT marginSam Chun Dang Pharm Co Profit margin
202447.25 %1.25 %-5.18 %
202350.33 %4.96 %-5.39 %
202250.75 %6.89 %3.29 %
202149.67 %-9.14 %-9.9 %
202056.33 %3.31 %-0.58 %
201959.3 %13.51 %5.6 %
201852.01 %9.69 %5.47 %
201752.78 %14.93 %7.79 %
201653.66 %16.53 %5.91 %
201554.53 %15.72 %8.8 %
201454.88 %15.93 %9.96 %
201354.15 %15.19 %8.34 %
201249.67 %7.77 %1.75 %
201153.1 %9.67 %7.3 %

Sam Chun Dang Pharm Co Aktienanalyse

What does Sam Chun Dang Pharm Co do?

Sam Chun Dang Pharm Co Ltd is a pharmaceutical company specializing in Korean herbal medicine. It was founded in 1947 and is headquartered in Seoul, South Korea. The company has undergone a profound transformation in recent decades to meet the growing demands of the healthcare industry. Sam Chun Dang believes that natural remedies can play an important role in promoting health and well-being. Therefore, the company has focused on manufacturing medicines from natural herbs and plants. Since its inception, the company has aimed for better healthcare and improved quality of life for its customers. In recent years, Sam Chun Dang has become the market leader in the production of herbal medicine in Korea. It produces a variety of medicines, including products for treating traditional Korean ailments such as fatigue, loss of appetite, and colds. The company maintains several research centers and production facilities to ensure the preservation of its products' high quality. These centers are equipped with state-of-the-art equipment and have carefully trained personnel. Sam Chun Dang essentially produces three types of products: herbal medicine, dietary supplements, and health products. Herbal medicine is made from natural ingredients such as ginseng, horsetail, angelica, atractylodes, and many other herbs. Each product undergoes strict control and testing to ensure they meet the highest standards. Sam Chun Dang also produces dietary supplements that possess a wide range of health-promoting properties. These supplements contain vitamins, minerals, proteins, and many other nutrients. They are designed to naturally promote and strengthen the body's health. Additionally, Sam Chun Dang also offers health products such as masks and cleansing products. These products aim to help improve the health and well-being of customers. Sam Chun Dang is an innovative company that is always striving to improve its products and services. Over the years, the company has received several awards recognizing its leadership qualities and innovative products. Overall, Sam Chun Dang Pharm Co Ltd is a leading manufacturer of herbal medicine and dietary supplements with a strong commitment to health. The company has made a name for itself in recent years through its dedication and innovations in manufacturing products from natural ingredients. Sam Chun Dang remains committed to making a positive contribution to the healthcare industry while continuing to provide high-quality and innovative products. Sam Chun Dang Pharm Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Sam Chun Dang Pharm Co's EBIT

Sam Chun Dang Pharm Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Sam Chun Dang Pharm Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Sam Chun Dang Pharm Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Sam Chun Dang Pharm Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Sam Chun Dang Pharm Co stock

How much did Sam Chun Dang Pharm Co achieve in EBIT for the current year?

In the current year, Sam Chun Dang Pharm Co has achieved an EBIT of 2.64 B KRW.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Sam Chun Dang Pharm Co.

How has the EBIT of Sam Chun Dang Pharm Co developed in recent years?

The EBIT of Sam Chun Dang Pharm Co has increased by -72.364% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Sam Chun Dang Pharm Co?

The EBIT of Sam Chun Dang Pharm Co is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Sam Chun Dang Pharm Co pay?

Over the past 12 months, Sam Chun Dang Pharm Co paid a dividend of 200 KRW . This corresponds to a dividend yield of about 0.13 %. For the coming 12 months, Sam Chun Dang Pharm Co is expected to pay a dividend of 200 KRW.

What is the dividend yield of Sam Chun Dang Pharm Co?

The current dividend yield of Sam Chun Dang Pharm Co is 0.13 %.

When does Sam Chun Dang Pharm Co pay dividends?

Sam Chun Dang Pharm Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Sam Chun Dang Pharm Co?

Sam Chun Dang Pharm Co paid dividends every year for the past 1 years.

What is the dividend of Sam Chun Dang Pharm Co?

For the upcoming 12 months, dividends amounting to 200 KRW are expected. This corresponds to a dividend yield of 0.13 %.

In which sector is Sam Chun Dang Pharm Co located?

Sam Chun Dang Pharm Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sam Chun Dang Pharm Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sam Chun Dang Pharm Co from 4/1/2025 amounting to 200 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.

When did Sam Chun Dang Pharm Co pay the last dividend?

The last dividend was paid out on 4/1/2025.

What was the dividend of Sam Chun Dang Pharm Co in the year 2024?

In the year 2024, Sam Chun Dang Pharm Co distributed 0 KRW as dividends.

In which currency does Sam Chun Dang Pharm Co pay out the dividend?

The dividends of Sam Chun Dang Pharm Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sam Chun Dang Pharm Co

Our stock analysis for Sam Chun Dang Pharm Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sam Chun Dang Pharm Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.